🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Francisco J. Hernandez‐Ilizaliturri

Roswell Park Comprehensive Cancer Center

ORCID: 0000-0001-8054-3539

Also affiliated with University at Buffalo, State University of New York

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: Results of the DIAL study (NCI 10089), a randomized phase 2 trial of varlilumab combined with nivolumab in patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma (r/r B-NHL)..

3 citations

Justin Kline, Aleksandr Lazaryan, Nancy L. Bartlett, Francisco J. Hernandez‐Ilizaliturri, Farrukh T. Awan +13 more

1 citations

Jessica Y. Islam, Cassandra Hennessy, Jun Yang Jiang, Sharad Goyal, Diana Vilar‐Compte +15 more

11 citations

Chao Xu, Samuel L. Galster, Javier Querol-García, Scott Portwood, Cory Mavis +12 more

0 citations

Francisco J. Hernandez‐Ilizaliturri, James L. Clements, Myron S. Czuczman, Scott H. Olejniczak

0 citations

Francisco J. Hernandez‐Ilizaliturri, James L. Clements, Myron S. Czuczman, Scott H. Olejniczak